June 3, 2024 · Form 4 insider transaction
Griffin Stephen D. bought 38,520 shares of Anika Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning June 3, 2025.